Neostigmine Methylsulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 10 USDMF, 6 CEP/COS, 2 JDMF, 11 EU WC, 11 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

71 FDF Dossiers, 42 FDA Orange Book, 1 Europe, 8 Canada, 2 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML), SOLUTION;INTRAVENOUS - 3MG/3ML (1MG/ML), SOLUTION;INTRAVENOUS - 5MG/10ML (0.5MG/ML), SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML), SOLUTION;INTRAVENOUS - 5MG/10ML (0.5MG/ML), SOLUTION;INTRAVENOUS - 5MG/5ML (1MG/ML)